Year Published
- 2008 (0)
- 2009 (12) Apply 2009 filter
- (-) Remove 2010 filter 2010
- 2011 (2) Apply 2011 filter
- 2012 (2) Apply 2012 filter
- 2013 (1) Apply 2013 filter
- (-) Remove 2014 filter 2014
- 2015 (7) Apply 2015 filter
- 2016 (8) Apply 2016 filter
- (-) Remove 2017 filter 2017
- 2018 (2) Apply 2018 filter
- 2019 (0)
- 2020 (0)
- (-) Remove 2021 filter 2021
Research Topics
Populations
Types of Research
Geography
- East Africa Region and Selected Countries (1) Apply East Africa Region and Selected Countries filter
- Global (7) Apply Global filter
- South Asia Region and Selected Countries (3) Apply South Asia Region and Selected Countries filter
- Southern Africa Region and Selected Countries (1) Apply Southern Africa Region and Selected Countries filter
- Sub-Saharan Africa (9) Apply Sub-Saharan Africa filter
- West Africa Region and Selected Countries (1) Apply West Africa Region and Selected Countries filter
Dataset
- ASTI (2) Apply ASTI filter
- FAOSTAT (2) Apply FAOSTAT filter
- Farmer First (0)
- LSMS & LSMS-ISA (0)
- Other Datasets (2) Apply Other Datasets filter
Current search
- (-) Remove Labor & Time Use filter Labor & Time Use
- (-) Remove 2017 filter 2017
- (-) Remove 2010 filter 2010
- (-) Remove Development Finance & Policy filter Development Finance & Policy
- (-) Remove 2014 filter 2014
- (-) Remove 2021 filter 2021
In this dataset, we compile current project data from three major international financial institutions (or IFIs) - the World Bank, African Development Bank, and the International Fund for Agricultural Development - to understand
- how much countries are borrowing from each institution. and
- how much of that funding is devoted to small scale producer agriculture.
We begin by gathering publicly accessible data through downloads and webscraping Python and R scripts. These data are then imported into the statistical software program, Stata, for cleaning and export to Excel for analysis. This dataset contains rich information about current projects (active, in implementation, or recently approved), such as project title, project description, borrowing ministry, commitment amount, and sector. We then code relevant projects into two categories: On Farm (projects pertaining directly to small scale producer agriculture) and Rural/Agricultural Economies (inclusive of On Farm, but broader to include projects that impact community livelihoods and wellbeing). Finally, we annualize and aggregate these coded projects by IFI and then by country for analysis. Bilateral funding, government expenditures on agriculture, and development indicators are also included as supporting data to add context to a country's progress towards agricultural transformation.
The primary utility of this dataset is having all projects collected in a single spreadsheet where it is possible to search by key terms (e.g. commodity, market, financial, value chain) for lending by IFI and country, and to get some level of project detail. We have categorized projects by lending category (e.g. irrigation, livestock, agricultural development, research/extention/training) to aggregate across IFI so that the total funding for any country is easier to find. For example, Ethiopia and Nigeria receive the most total lending from these IFIs (though not on a per capita basis), with each country receiving more than $3 billion per year on average. Ethiopia receives the most lending devoted to On Farm projects, roughly $585 million per year. Overall, these data provide a snapshot of the magnitude and direction of these IFI's lending over the past several years to sub-Saharan Africa.
Suggested Citation:
Figone, K., Porton, A., Kiel, S., Hariri, B., Kaminsky, M., Alia, D., Anderson, C.L., and Trindade, F. (2021). Summary of Three International Financial Institution (IFI) Investments in Sub-Saharan Africa. EPAR Technical Report #411. Evans School of Public Policy & Governance, University of Washington. Retrieved <Day Month Year> from https://epar.evans.uw.edu/research/tracking-investment-landscape-summary-three-international-financial-institutions-ifis
The share of private sector funding, relative to public sector funding, for drug, vaccine, and diagnostic research & development (R&D) differs considerably across diseases. Private sector investment in overall health R&D exceeds $150 billion annually, but is largely concentrated on non-communicable chronic diseases with only an estimated $5.9 billion focused on "global health", targeting diseases that primarily affect low and middle-income countries (LMICs). We examine the evidence for five specific disincentives to private sector global health R&D investment: scientific uncertainty, weak policy environments, limited revenues and market uncertainty, high fixed and sunk costs, and downstream rents from imperfect markets. Though all five may affect estimates of net returns from an investment decision, they are worth examining separately as each calls for a different intervention or remediation to change behavior.
Donor countries and multilateral organizations may pursue multiple goals with foreign aid, including supporting low-income country development for strategic/security purposes (national security, regional political stability) and for short-and long-term economic interests (market development and access, local and regional market stability). While the literature on the effectiveness of aid in supporting progress on different indicators of country development is inconclusive, donors are interested in evidence that aid funding is not permanent but rather contributes to a process by which recipient countries develop to a point that they are economically self-sufficient. In this report, we review the literature on measures of country self-sufficiency and descriptive evidence from illustrative case studies to explore conditions associated with transitions toward self-sufficiency in certain contexts.
Cash transfer programs are interventions that directly provide cash to target specific populations with the aim of reducing poverty and supporting a variety of development outcomes. Low- and middle-income countries have increasingly adopted cash transfer programs as central elements of their poverty reduction and social protection strategies. Bastagli et al. (2016) report that around 130 low- and middle-income countries have at least one UCT program, and 63 countries have at least one CCT program (up from 27 countries in 2008). Through a comprehensive review of literature, this report primarily considers the evidence of the long-term impacts of cash transfer programs in low- and lower middle-income countries. A review of 54 reviews that aggregate and summarize findings from multiple studies of cash transfer programs reveals largely positive evidence on long-term outcomes related to general health, reproductive health, nutrition, labor markets, poverty, and gender and intra-household dynamics, though findings vary by context and in many cases overall conclusions on the long-term impacts of cash transfers are mixed. In addition, evidence on long-term impacts for many outcome measures is limited, and few studies explicitly aim to measure long-term impacts distinctly from immediate or short-term impacts of cash transfers.
An ongoing stream of EPAR research considers how public good characteristics of different types of research and development (R&D) and the motivations of different providers of R&D funding affect the relative advantages of alternative funding sources. For this project, we seek to summarize the key public good characteristics of R&D investment for agriculture in general and for different subsets of crops, and hypothesize how these characteristics might be expected to affect public, private, or philanthropic funders’ investment decisions.
The concept of global public goods represents a framework for organizing and financing international cooperation in global health research and development (R&D). Advances in scientific and clinical knowledge produced by biomedical R&D can be considered public goods insofar as they can be used repeatedly (non-rival consumption) and it is difficult or costly to exclude non-payers from gaining access (non-excludable). This paper considers the public good characteristics of biomedical R&D in global health and describes the theoretical and observed factors in the allocation R&D funding by public, private, and philanthropic sources.
A “new wave” of digital credit products has entered the digital financial services (DFS) market in recent years. These products differ from traditional credit by offering loans to borrowers that can be applied for, approved, and disbursed remotely (often without any brick-and-mortar infrastructure), automatically (generally minimizing or eliminating person-to-person interaction), and instantly (often in less than 72 hours). Digital credit also increasingly considers creditworthiness by using alternative (nontraditional) data—ranging from mobile phone activity to utility payments and social media data—potentially allowing for loans to populations previously unable to access bank credit. Two EPAR reports review the characteristics of digital credit offerings in India, Kenya, Nigeria, Tanzania, and Uganda, and regulations specific to digital credit in Africa and Asia.
This report draws on past and present peer-reviewed articles and published reports by institutions including the World Health Organization (WHO), the UK Department for International Development (DFID), and others to provide a scoping summary of the household-level spillovers and broader impacts of a select group of health initiatives. Rather than focusing on estimates of the direct health impacts of investments (e.g., reductions in mortality from vaccine delivery), we focus on estimates of the less-often reported spillover effects of specific health investments on household welfare or the broader economy. The brief is designed to give a concise overview of major theories linking health improvements to broader social and economic outcomes, followed by more in-depth summaries of available local- and country-level estimates of broader impacts, defined as project spillovers offering local, regional and national social and economic benefits not typically reported in project evaluations.
This report summarizes current trends in the application of Development Finance Institution (DFI)-based returnable capital finance in developing countries, with an emphasis on “pro-poor” development initiatives. We begin by reviewing the financial instruments used by DFIs. We then review the major DFI providers of returnable-capital based finance, drawing on past and present peer-reviewed articles and published reports exploring trends in the uses of different returnable capital instruments over time. Finally, we conclude by further examining recent efforts to use returnable capital to finance development initiatives explicitly targeting the poor.